Dr. Lal PathLabs Limited
Dr. Lal PathLabs Limited scores highest on Nitro (87) and lowest on Price (19). Its PosiPenta is 61.67 out of 100, better than most similar companies.
On the Penta Grid this week, Dr. Lal PathLabs Limited is Grid #22 of 164 in the Healthcare sector in India, and Grid #293 of 2,328 in India.
Compared with similar companies in the Healthcare sector in India.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Dr. Lal PathLabs Limited | 61.67 | 19 | 49 | 87 | 76 | 77 |
| Wockhardt Limited | 42.53 | 23 | 68 | 60 | 26 | 36 |
| Sai Life Sciences Limited | 46.85 | 14 | 50 | 74 | 59 | 37 |
| Global Health Limited | 46.59 | 22 | 65 | 47 | 46 | 53 |
| Emcure Pharmaceuticals Limited | 58.76 | 43 | 63 | 70 | 60 | 59 |
| Krishna Institute of Medical Sciences Limited | 34.51 | 10 | 59 | 42 | 15 | 46 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 57.40 |
| P/B ratio | 12.40 |
EEarnings
| Trailing EPS | ₹32.40 |
| Forward EPS | ₹43.78 |
NNitro
| Price | 1859.90 |
| 52-week high | 2038.60 |
| 52-week low | 1272.60 |
| Fall from 52-week high | 8.8% |
TTorque
| Return on equity (ROE) (calculated) | 21.60% |
| Debt-to-equity | 0.08 |
AAnchor
| Beta (price swings) | 0.16 |
| Market cap | ₹31,099 Cr |
| Promoter holding | 53.19% |
| Dividend yield | 1.03% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Dr. Lal PathLabs Limited's PosiPenta score?
Dr. Lal PathLabs Limited's PosiPenta is 61.67 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Dr. Lal PathLabs Limited stand on the Penta Grid?
On the Penta Grid this week, Dr. Lal PathLabs Limited is Grid #22 of 164 in the Healthcare sector in India, and Grid #293 of 2,328 in India.
Which PosiPenta pillar is strongest for Dr. Lal PathLabs Limited?
Nitro (momentum), with a score of 87 out of 100: much better than most similar companies.
Which PosiPenta pillar is weakest for Dr. Lal PathLabs Limited?
Price (valuation), with a score of 19 out of 100: much weaker than most similar companies.
Has Dr. Lal PathLabs Limited's PosiPenta changed since last week?
Yes, it fell 0.81 points, from 62.48 to 61.67.
PositoAI is for research and education only and is not investment advice.